Atopic dermatitis is a common inflammatory disease but the economic burden of is not well understood. In one of our most recent publications, Quantify authors; Gustaf Ortsäter, Alexander Rieem Dun and Kirk Geale showed that atopic dermatitis was associated […]
Have you seen our new demo, demonstrating our capabilities in Power BI? Power BI is an excellent tool designed to make complex data such as register-based RWE more accessible to broader audiences, […]
A “cross-Nordic RWE study” includes an analysis of data from multiple Nordic countries. In 2022, Quantify published 8 papers, based on EMPRISE, BISCUITS, NORDSTAR and the ATTR-CM study, providing important evidence on Nordic-wide comparative effectiveness, treatment patterns and unmet needs, […]
From the entire Quantify team to all of our clients, collaborators and friends – Happy Holidays and Happy New Year! We hope that 2023 brings happiness and success to you all. […]
Last week we excitedly welcomed our newest team member Dr Neha Singh as Manager within our Evidence review & synthesis unit!
Neha is enthusiastic, passionate, and has a deep interest in the subject of research which she owes to her PhD […]
A description of the use of ALK-TKI treatment for patients with ALK positive advanced non-small cell lung cancer, co-authored by Quantify’s Rosa Lauppe and Mathias Lilja, has been published in the Acta […]
Quantify partner Anders Gustavsson participated in a panel on Alzheimer innovations and capacity challenges within the Swedish health care system. We call for 1) a National Alzheimer plan including a priority framework to identify and treat patients with the greatest potential benefit, […]
It’s been another great day at #isporeurope! We’ve had a full day discussing […]
We’ve had a great first day at ISPOR in Vienna! The team presented a variety of research posters, connected with our colleagues and […]